"Hypersynchronisation" by tissue velocity imaging in patients with cardiac amyloidosis

被引:18
作者
Bellavia, D. [1 ]
Pellikka, P. A. [1 ]
Abraham, T. P. [1 ]
Al-Zahrani, G. B. [1 ]
Dispenzieri, A. [2 ]
Oh, J. K. [1 ]
Espinosa, R. E. [1 ]
Scott, C. G. [3 ]
Miyazaki, C. [1 ]
Miller, F. A. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hematol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Biostat, Rochester, MN 55905 USA
关键词
BRAIN NATRIURETIC PEPTIDE; STEM-CELL TRANSPLANTATION; SYSTEMIC AMYLOIDOSIS; CONDUCTION SYSTEM; LIGHT-CHAINS; ECHOCARDIOGRAPHY; ABNORMALITIES; DYSFUNCTION;
D O I
10.1136/hrt.2007.140343
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: It is unknown if some patients with cardiac amyloidosis (CA) have mechanical dyssynchrony, as has been demonstrated in patients with ischaemic and dilated cardiomyopathies. The aim of this study was to assess mechanical dyssynchrony in patients with CA using tissue velocity imaging (TVI) and to define its usefulness for risk stratification. Design and patients: We included 121 patients with primary amyloidosis and 37 age-matched and sex-matched controls. Patients were divided into two groups: 60 with advanced-CA and 61 with no-advanced-CA, according to left ventricular (LV) wall thickness and diastolic dysfunction. Dyssynchrony assessment included: (1) atrioventricular dyssynchrony (dys), (2) interventricular dys, (3) intraventricular dys assessed longitudinally, using the standard deviation of time to systolic peak velocity (Ts-SD) of the 12 basal and mid level LV segments, and (4) intraventricular dys assessed radially, using the difference in radial Ts between mid anteroseptal and mid posterior segments. Outcome: Primary end-point was all-cause death. During a median follow-up of 13 months there were 35 events among patients. Results: Contrary to the hypothesis, the intraventricular dys indices in advanced-CA patients were reduced compared to either the no-advanced-CA group or to controls (Ts-SD: 12.1 (9.0); 35.1 (18.6); 24.5 (14.1), respectively, p < 0.001). This reduction was primarily the result of decreased ejection time (ET). Moreover, ET was the most significant predictor of survival (HR = 0.98, p < 0.001). Conclusions: The regional timing of systolic motion measured by TVI was abnormally synchronised in the patients with advanced-CA. ET reduction plays a prominent part in this process and should be considered an essential parameter for assessment of patients with cardiac amyloidosis.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 15 条
[1]
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy [J].
Bax, JJ ;
Bleeker, GB ;
Marwick, TH ;
Molhoek, SG ;
Boersma, E ;
Steendijk, P ;
van der Wall, EE ;
Schalij, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1834-1840
[2]
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress [J].
Brenner, DA ;
Jain, M ;
Pimentel, DR ;
Wang, B ;
Connors, LH ;
Skinner, M ;
Apstein, CS ;
Liao, RL .
CIRCULATION RESEARCH, 2004, 94 (08) :1008-1010
[3]
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation [J].
Dispenzieri, A ;
Gertz, MA ;
Kyle, RA ;
Lacy, MQ ;
Burritt, MF ;
Therneau, TM ;
McConnell, JP ;
Litzow, MR ;
Gastineau, DA ;
Tefferi, A ;
Inwards, DJ ;
Micallef, IN ;
Ansell, SM ;
Porrata, LF ;
Elliott, MA ;
Hogan, WJ ;
Rajkumar, SV ;
Fonseca, R ;
Greipp, PR ;
Witzig, TE ;
Lust, JA ;
Zeldenrust, SR ;
Snow, DS ;
Hayman, SR ;
McGregor, CGA ;
Jaffe, AS .
BLOOD, 2004, 104 (06) :1881-1887
[4]
Diagnosis and management of the cardiac amyloidoses [J].
Falk, RH .
CIRCULATION, 2005, 112 (13) :2047-2060
[5]
CARDIAC-ARRHYTHMIAS IN SYSTEMIC AMYLOIDOSIS - CORRELATION WITH ECHOCARDIOGRAPHIC ABNORMALITIES [J].
FALK, RH ;
RUBINOW, A ;
COHEN, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (01) :107-113
[6]
PATHOLOGY OF CARDIAC CONDUCTION SYSTEM IN AMYLOIDOSIS [J].
JAMES, TN .
ANNALS OF INTERNAL MEDICINE, 1966, 65 (01) :28-+
[7]
Selection and optimisation of biventricular pacing: the role of echocardiography [J].
Lane, RE ;
Chow, AWC ;
Chin, D ;
Mayet, J .
HEART, 2004, 90 :10-16
[8]
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology [J].
Lang, RM ;
Bierig, M ;
Devereux, RB ;
Flachskampf, FA ;
Foster, E ;
Pellikka, PA ;
Picard, MH ;
Roman, MJ ;
Seward, J ;
Shanewise, JS ;
Solomon, SD ;
Spencer, KT ;
Sutton, MS ;
Stewart, WJ .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2005, 18 (12) :1440-1463
[9]
Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts [J].
Liao, RL ;
Jain, M ;
Teller, P ;
Connors, LH ;
Ngoy, S ;
Skinner, M ;
Falk, RH ;
Apstein, CS .
CIRCULATION, 2001, 104 (14) :1594-1597
[10]
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis [J].
Palladini, G ;
Campana, C ;
Klersy, C ;
Balduini, A ;
Vadacca, G ;
Perfetti, V ;
Perlini, S ;
Obici, L ;
Ascari, E ;
d'Eril, GM ;
Moratti, R ;
Merlini, G .
CIRCULATION, 2003, 107 (19) :2440-2445